Search research articles
Contact Us
Filters
Showing results (31-40 of 91) with videos related to
Page
of 10
Sort By:
Journal of Neuro-Oncology
|
January 22, 2024
Pineal anlage tumor: clinical and diagnostic features, and rationales for treatment
Denise Obrecht-Sturm, Elke Pfaff, Martin Mynarek, et al.
Acta Neuropathologica Communications
|
November 16, 2019
Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features - a retrospective analysis of the HIT ependymoma trial cohort
Stephanie T Jünger, Martin Mynarek, Inken Wohlers, et al.
Clinical Chemistry
|
August 25, 2023
Classification of Brain Tumors by Nanopore Sequencing of Cell-Free DNA from Cerebrospinal Fluid
Ann-Kristin Afflerbach, Christian Rohrandt, Björn Brändl, et al.
Neuro-Oncology Practice
|
May 14, 2026
Neuropsychological late effects in young children with medulloblastoma: A longitudinal analysis after 5 and 15 years from the HIT-SKK-'87/'92 studies
Holger Ottensmeier, Matthias Eyrich, René Schmidt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 12, 2022
Refining M1 stage in medulloblastoma: criteria for cerebrospinal fluid cytology and implications for improved risk stratification from the HIT-2000 trial
Christian Hagel, Veronika Sloman, Martin Mynarek, et al.
Neuroradiology
|
February 17, 2025
Recurrence patterns in pediatric intracranial ependymal neoplasm: a systematic imaging work-up
Annika Stock, Judith Krumma, Gudrun Fleischhack, et al.
Journal of Neuro-Oncology
|
October 17, 2021
Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies
Jonas E Adolph, Gudrun Fleischhack, Christine Gaab, et al.
Acta Neuropathologica
|
June 10, 2020
CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort
Stephanie T Jünger, Felipe Andreiuolo, Martin Mynarek, et al.
Neuro-Oncology
|
April 5, 2024
Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent magnetic resonance imaging lesions after first-line treatment
Denise Obrecht-Sturm, Lena Schömig, Martin Mynarek, et al.
Journal of Neurosurgery. Pediatrics
|
June 19, 2026
Incomplete tumor resection, central neuroradiological review, and second surgery in pediatric patients with intracranial ependymoma treated in the E-HIT2000 trial
Kara L Krajewski, Gertrud Kammler, Denise Obrecht-Sturm, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 91) with videos related to
Sort By:
Page
of 10
Journal of Neuro-Oncology
|
January 22, 2024
Pineal anlage tumor: clinical and diagnostic features, and rationales for treatment
Denise Obrecht-Sturm, Elke Pfaff, Martin Mynarek, et al.
Acta Neuropathologica Communications
|
November 16, 2019
Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features - a retrospective analysis of the HIT ependymoma trial cohort
Stephanie T Jünger, Martin Mynarek, Inken Wohlers, et al.
Clinical Chemistry
|
August 25, 2023
Classification of Brain Tumors by Nanopore Sequencing of Cell-Free DNA from Cerebrospinal Fluid
Ann-Kristin Afflerbach, Christian Rohrandt, Björn Brändl, et al.
Neuro-Oncology Practice
|
May 14, 2026
Neuropsychological late effects in young children with medulloblastoma: A longitudinal analysis after 5 and 15 years from the HIT-SKK-'87/'92 studies
Holger Ottensmeier, Matthias Eyrich, René Schmidt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 12, 2022
Refining M1 stage in medulloblastoma: criteria for cerebrospinal fluid cytology and implications for improved risk stratification from the HIT-2000 trial
Christian Hagel, Veronika Sloman, Martin Mynarek, et al.
Neuroradiology
|
February 17, 2025
Recurrence patterns in pediatric intracranial ependymal neoplasm: a systematic imaging work-up
Annika Stock, Judith Krumma, Gudrun Fleischhack, et al.
Journal of Neuro-Oncology
|
October 17, 2021
Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies
Jonas E Adolph, Gudrun Fleischhack, Christine Gaab, et al.
Acta Neuropathologica
|
June 10, 2020
CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort
Stephanie T Jünger, Felipe Andreiuolo, Martin Mynarek, et al.
Neuro-Oncology
|
April 5, 2024
Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent magnetic resonance imaging lesions after first-line treatment
Denise Obrecht-Sturm, Lena Schömig, Martin Mynarek, et al.
Journal of Neurosurgery. Pediatrics
|
June 19, 2026
Incomplete tumor resection, central neuroradiological review, and second surgery in pediatric patients with intracranial ependymoma treated in the E-HIT2000 trial
Kara L Krajewski, Gertrud Kammler, Denise Obrecht-Sturm, et al.
Page
of 10